184 related articles for article (PubMed ID: 34693523)
1. Incidence of paediatric multiple sclerosis and other acquired demyelinating syndromes: 10-year follow-up surveillance study.
Abdel-Mannan O; Absoud M; Benetou C; Hickson H; Hemingway C; Lim M; Wright S; Hacohen Y; Wassmer E;
Dev Med Child Neurol; 2022 Apr; 64(4):502-508. PubMed ID: 34693523
[TBL] [Abstract][Full Text] [Related]
2. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.
Duignan S; Wright S; Rossor T; Cazabon J; Gilmour K; Ciccarelli O; Wassmer E; Lim M; Hemingway C; Hacohen Y
Dev Med Child Neurol; 2018 Sep; 60(9):958-962. PubMed ID: 29468668
[TBL] [Abstract][Full Text] [Related]
3. Long-term trajectory of acquired demyelinating syndrome and multiple sclerosis in children.
Eusebi A; Zara P; Zarbo IR; Festa S; Dessì V; Pes V; Salis F; Sotgiu G; Carta A; Sotgiu S
Dev Med Child Neurol; 2021 Sep; 63(9):1059-1065. PubMed ID: 33938575
[TBL] [Abstract][Full Text] [Related]
4. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
5. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
[TBL] [Abstract][Full Text] [Related]
6. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes.
Ferilli MAN; Valeriani M; Papi C; Papetti L; Ruscitto C; Figà Talamanca L; Ursitti F; Moavero R; Vigevano F; Iorio R
Mult Scler Relat Disord; 2021 May; 50():102837. PubMed ID: 33636614
[TBL] [Abstract][Full Text] [Related]
7. Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis.
Hintzen RQ; Dale RC; Neuteboom RF; Mar S; Banwell B
Neurology; 2016 Aug; 87(9 Suppl 2):S67-73. PubMed ID: 27572864
[TBL] [Abstract][Full Text] [Related]
8. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Bruijstens AL; Lechner C; Flet-Berliac L; Deiva K; Neuteboom RF; Hemingway C; Wassmer E; ; Baumann M; Bartels F; Finke C; Adamsbaum C; Hacohen Y; Rostasy K
Eur J Paediatr Neurol; 2020 Nov; 29():2-13. PubMed ID: 33162302
[TBL] [Abstract][Full Text] [Related]
9. Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.
Gudbjornsson BT; Haraldsson Á; Einarsdóttir H; Thorarensen Ó
Pediatr Neurol; 2015 Dec; 53(6):503-7. PubMed ID: 26463471
[TBL] [Abstract][Full Text] [Related]
10. MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein.
Baumann M; Grams A; Djurdjevic T; Wendel EM; Lechner C; Behring B; Blaschek A; Diepold K; Eisenkölbl A; Fluss J; Karenfort M; Koch J; Konuşkan B; Leiz S; Merkenschlager A; Pohl D; Schimmel M; Thiels C; Kornek B; Schanda K; Reindl M; Rostásy K
J Neurol; 2018 Apr; 265(4):845-855. PubMed ID: 29423614
[TBL] [Abstract][Full Text] [Related]
11. E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Baumann M; Bartels F; Finke C; Adamsbaum C; Hacohen Y; Rostásy K;
Eur J Paediatr Neurol; 2020 Nov; 29():14-21. PubMed ID: 33158737
[TBL] [Abstract][Full Text] [Related]
12. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults.
de Mol CL; Wong Y; van Pelt ED; Wokke B; Siepman T; Neuteboom RF; Hamann D; Hintzen RQ
Mult Scler; 2020 Jun; 26(7):806-814. PubMed ID: 31094288
[TBL] [Abstract][Full Text] [Related]
13. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
[TBL] [Abstract][Full Text] [Related]
14. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
[TBL] [Abstract][Full Text] [Related]
15. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.
Waters P; Fadda G; Woodhall M; O'Mahony J; Brown RA; Castro DA; Longoni G; Irani SR; Sun B; Yeh EA; Marrie RA; Arnold DL; Banwell B; Bar-Or A;
JAMA Neurol; 2020 Jan; 77(1):82-93. PubMed ID: 31545352
[TBL] [Abstract][Full Text] [Related]
16. Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children.
Yoo IH; Kim W; Shim Y; Choi SA; Kim SY; Kim H; Lim BC; Hwang H; Choi J; Kim KJ; Kim Y; Hyun JW; Kim SH; Choi K; Kim HJ; Chae JH
J Clin Neurol; 2020 Jul; 16(3):461-469. PubMed ID: 32657068
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.
Hacohen Y; Absoud M; Woodhall M; Cummins C; De Goede CG; Hemingway C; Jardine PE; Kneen R; Pike MG; Whitehouse WP; Wassmer E; Waters P; Vincent A; Lim M;
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):456-61. PubMed ID: 24133290
[TBL] [Abstract][Full Text] [Related]
18. Clinical and MRI phenotype of children with MOG antibodies.
Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
[TBL] [Abstract][Full Text] [Related]
19. Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
Wong YYM; Hacohen Y; Armangue T; Wassmer E; Verhelst H; Hemingway C; van Pelt ED; Catsman-Berrevoets CE; Hintzen RQ; Deiva K; Lim MJ; Rostásy K; Neuteboom RF
Eur J Neurol; 2018 May; 25(5):782-786. PubMed ID: 29443442
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.
Hino-Fukuyo N; Haginoya K; Nakashima I; Sato DK; Takahashi T; Misu T; Fujihara K; Hirose M; Kakisaka Y; Uematsu M; Kobayashi T; Kure S
Brain Dev; 2015 Oct; 37(9):849-52. PubMed ID: 25748628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
